Taking a bold step into the world of bundled payment models can help an organization transform itself, but it could fail.
Organizations that want to change are not the same as organizations that are willing to change. It takes a bold leader to make recommendations that may be new and uncomfortable to the organization. As consultants who analyze complex data on a daily basis, we’re constantly steering our clients to make decisions—including some that may be well outside of their comfort zone. The trend toward more mandatory bundled payment models from CMS will be a forcing function that pushes organizations to make bold decisions and transform their businesses—or fail.
Voluntary models like BPCI-Advanced (BPCI-A), the successor to Bundled Payments for Care Improvement, should be viewed as a sandbox to prepare for this future of mandatory alternative payment models. Now is the time to raise the bar on what’s comfortable — and keep raising it. Now is the time to be bold.
We are passionate about using bundled payment models as innovative solutions for business transformation. Participation can lead to improved quality outcomes and patient/provider satisfaction while lowering costs, and using these models will prepare organizations for the future of value-based care.
Here are 4 things to think about when analyzing whether BPCI-A is right for your organization:
Give your organization a leg up in the value-based care environment of tomorrow by moving boldly towards this change today. More mandatory bundled payment models are coming, so it makes sense to the experience you need to effect positive change. BPCI-A can be a great means to decrease readmissions, length of stay, and post-acute utilization while improving internal cost savings, patient/provider satisfaction, and achieving CMS savings. If that sounds good, ask yourself these 3 questions: Do you want to change? Are you willing to change? Are you willing to lead boldly?
Author Information
Darcie Hurteau, MBA, is senior director, DataGen. Tamara Cull, DHA, is senior vice president, Aveus.
About Aveus
The Aveus team offers 20 years of experience in providing strategic consulting, operational and advisory services, value-based program design, integrated care management models, and innovation implementation.
About DataGen
DataGen is an essential partner to healthcare organizations across the country, illustrating the financial implications of payment policy changes and promoting a pragmatic view of how changes will affect revenue and profitability.
PAH Treatment Outcomes Similar Regardless of Diagnosis Time
November 1st 2024The study findings underscore the importance of early initiation of macitentan and tadalafil among patients who have pulmonary arterial hypertension (PAH), and represent a shift in understanding of prognosis based on diagnosis timing.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
PAH Treatment Outcomes Similar Regardless of Diagnosis Time
November 1st 2024The study findings underscore the importance of early initiation of macitentan and tadalafil among patients who have pulmonary arterial hypertension (PAH), and represent a shift in understanding of prognosis based on diagnosis timing.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
2 Commerce Drive
Cranbury, NJ 08512